id	domain	url
catalyst-41952	www.catalystjournal.org	http://www.catalystjournal.org
catalyst-41952	doi.org	https://doi.org/10.1097/mog.0b013e32835a4b3e
catalyst-41952	doi.org	https://doi.org/10.1038/nature09944
catalyst-41952	doi.org	https://doi.org/10.1016/j.cgh.2011.08.014
catalyst-41952	doi.org	https://doi.org/10.1080/14649365.2019.1593490
catalyst-41952	doi.org	https://doi.org/10.1111/maq.12680
catalyst-41952	doi.org	https://doi.org/10.1177/0162243920911998
catalyst-41952	doi.org	https://doi.org/10.1073/pnas.1200515109
catalyst-41952	doi.org	http://doi.org/10.22459/ahr.50.2011
catalyst-41952	doi.org	https://doi.org/10.1080/15265161.2017.1299241
catalyst-41952	doi.org	https://doi.org/10.1215/22011919-9712379
catalyst-41952	doi.org	https://doi.org/10.1016/bs.pmbts.2022.06.031
catalyst-41952	doi.org	https://doi.org/10.1136/gutjnl-2016-313017
catalyst-41952	doi.org	https://doi.org/10.1097/mog.0b013e32835a4b3e
catalyst-41952	doi.org	https://doi.org/10.1038/nature09944
catalyst-41952	doi.org	https://doi.org/10.1016/j.cgh.2011.08.014
catalyst-41952	doi.org	https://doi.org/10.1080/14649365.2019.1593490
catalyst-41952	doi.org	https://doi.org/10.1111/maq.12680
catalyst-41952	doi.org	https://doi.org/10.1177/0162243920911998
catalyst-41952	doi.org	https://doi.org/10.1073/pnas.1200515109
catalyst-41952	doi.org	http://doi.org/10.22459/ahr.50.2011
catalyst-41952	doi.org	https://doi.org/10.1080/15265161.2017.1299241
catalyst-41952	doi.org	https://doi.org/10.1215/22011919-9712379
catalyst-41952	doi.org	https://doi.org/10.1016/bs.pmbts.2022.06.031
catalyst-41952	doi.org	https://doi.org/10.1136/gutjnl-2016-313017
catalyst-41952	doi.org	https://doi.org/10.1016%2fj.gpb.2018.02.004
catalyst-41952	doi.org	https://doi.org/10.1093/ajcn/nqy175
catalyst-41952	doi.org	https://doi.org/10.1038/nature11319
catalyst-41952	doi.org	https://doi.org/10.1371/journal.pone.0276295
catalyst-41952	doi.org	https://doi.org/10.11646/zootaxa.4979.1.22
catalyst-41952	doi.org	https://doi.org/10.1128/msystems.00604-21
catalyst-41952	doi.org	https://doi.org/10.1016/j.biopsych.2022.10.011
catalyst-41952	escholarship.mcgill.ca	https://escholarship.mcgill.ca/concern/theses/pk02cg71w
catalyst-41952	doi.org	https://doi.org/10.5206/fpq/2021.3.10839
catalyst-41952	doi.org	https://doi.org/10.3138/ijfab-2022-0005
catalyst-41952	doi.org	https://doi.org/10.1016%2fj.gpb.2018.02.004
catalyst-41952	doi.org	https://doi.org/10.1093/ajcn/nqy175
catalyst-41952	doi.org	https://doi.org/10.1038/nature11319
catalyst-41952	doi.org	https://doi.org/10.1371/journal.pone.0276295
catalyst-41952	doi.org	https://doi.org/10.11646/zootaxa.4979.1.22
catalyst-41952	doi.org	https://doi.org/10.1128/msystems.00604-21
catalyst-41952	doi.org	https://doi.org/10.1016/j.biopsych.2022.10.011
catalyst-41952	doi.org	https://doi.org/10.5206/fpq/2021.3.10839
catalyst-41952	doi.org	https://doi.org/10.3138/ijfab-2022-0005
catalyst-41952	freakonomics.com	https://freakonomics.com/podcast/the-power-of-poop/
catalyst-41952	www.washingtonpost.com	https://www.washingtonpost.com/news/speaking-ofscience/wp/2015/01/29/you-can-earn-13000-a-year-selling-your-poop/
catalyst-41952	ferringusa.com	https://ferringusa.com/?press=ferring-receivesu-s-fda-approval-for-rebyota-fecal-microbiota-live-jslm-a-novel-first-in-classmicrobiota-based-live-biotherapeutic
catalyst-41952	doi.org	https://doi.org/10.1126/science.1124234
catalyst-41952	muse.jhu.edu	https://muse.jhu.edu/article/786389
catalyst-41952	doi.org	https://doi.org/10.1057/s41599-020-0388-5
catalyst-41952	doi.org	https://doi.org/10.1136/gutjnl-2019-320260
catalyst-41952	www.biomedcentral.com	http://www.biomedcentral.com/1755-8794/4/72
catalyst-41952	freakonomics.com	https://freakonomics.com/podcast/the-power-of-poop
catalyst-41952	www.washingtonpost.com	https://www.washingtonpost.com/news/speaking-of-science/wp/2015/01/29/you-can-earn-13000-a-year-selling-your-poop
catalyst-41952	www.washingtonpost.com	https://www.washingtonpost.com/news/speaking-of-science/wp/2015/01/29/you-can-earn-13000-a-year-selling-your-poop
catalyst-41952	ferringusa.com	https://ferringusa.com/?press=ferring-receives-u-s-fda-approval-for-rebyota-fecal-microbiota-live-jslm-a-novel-first-in-class-microbiota-based-live-biotherapeutic
catalyst-41952	ferringusa.com	https://ferringusa.com/?press=ferring-receives-u-s-fda-approval-for-rebyota-fecal-microbiota-live-jslm-a-novel-first-in-class-microbiota-based-live-biotherapeutic
catalyst-41952	ferringusa.com	https://ferringusa.com/?press=ferring-receives-u-s-fda-approval-for-rebyota-fecal-microbiota-live-jslm-a-novel-first-in-class-microbiota-based-live-biotherapeutic
catalyst-41952	doi.org	https://doi.org/10.1126/science.1124234
catalyst-41952	muse.jhu.edu	https://muse.jhu.edu/article/786389
catalyst-41952	doi.org	https://doi.org/10.1057/s41599-020-0388-5
catalyst-41952	doi.org	https://doi.org/10.1136/gutjnl-2019-320260
catalyst-41952	www.biomedcentral.com	http://www.biomedcentral.com/1755-8794/4/72
catalyst-41952	doi.org	https://doi.org/10.1007/s10886-005-6081-8
catalyst-41952	doi.org	https://doi.org/10.1002/9780470015902.a0005849.pub2
catalyst-41952	doi.org	https://doi.org/10.1177/1073110519897725
catalyst-41952	doi.org	https://doi.org/10.1016%2fj.endeavour.2022.100817
catalyst-41952	doi.org	https://doi.org/10.1177/02637758211050936
catalyst-41952	doi.org	https://doi.org/10.1177/0047281620947355
catalyst-41952	doi.org	https://doi.org/10.1002/fea2.12123
catalyst-41952	doi.org	https://doi.org/10.1128/msystems.00471-21
catalyst-41952	patents.google.com	https://patents.google.com/patent/us9782445b2/en
catalyst-41952	doi.org	https://doi.org/10.1186/s12905-020-01000-x
catalyst-41952	doi.org	https://doi.org/10.1007/s10886-005-6081-8
catalyst-41952	doi.org	https://doi.org/10.1002/9780470015902.a0005849.pub2
catalyst-41952	doi.org	https://doi.org/10.1177/1073110519897725
catalyst-41952	doi.org	https://doi.org/10.1016%2fj.endeavour.2022.100817
catalyst-41952	doi.org	https://doi.org/10.1177/02637758211050936
catalyst-41952	doi.org	https://doi.org/10.1177/0047281620947355
catalyst-41952	doi.org	https://doi.org/10.1002/fea2.12123
catalyst-41952	doi.org	https://doi.org/10.1128/msystems.00471-21
catalyst-41952	patents.google.com	https://patents.google.com/patent/us9782445b2/en
catalyst-41952	doi.org	https://doi.org/10.1186/s12905-020-01000-x
catalyst-41952	doi.org	https://doi.org/10.1177/2050640620967898
catalyst-41952	doi.org	https://doi.org/10.1053/j.gastro.2020.09.038
catalyst-41952	doi.org	https://doi.org/10.1177/1073110519897726
catalyst-41952	doi.org	https://doi.org/10.1080/01459740.2010.531064
catalyst-41952	doi.org	https://doi.org/10.1111/1467-9566.13584
catalyst-41952	doi.org	https://doi.org/10.1093/beheco/arw113
catalyst-41952	doi.org	https://doi.org/10.1215/22011919-8623208
catalyst-41952	doi.org	https://doi.org/10.1080/14735784.2020.1857810
catalyst-41952	doi.org	https://doi.org/10.1007/s10886-010-9864-5
catalyst-41952	doi.org	https://doi.org/10.1177/0263276417695866
catalyst-41952	doi.org	https://doi.org/10.1111/maq.12466
catalyst-41952	doi.org	https://doi.org/10.1177/2050640620967898
catalyst-41952	doi.org	https://doi.org/10.1053/j.gastro.2020.09.038
catalyst-41952	doi.org	https://doi.org/10.1177/1073110519897726
catalyst-41952	doi.org	https://doi.org/10.1080/01459740.2010.531064
catalyst-41952	doi.org	https://doi.org/10.1111/1467-9566.13584
catalyst-41952	doi.org	https://doi.org/10.1093/beheco/arw113
catalyst-41952	doi.org	https://doi.org/10.1215/22011919-8623208
catalyst-41952	doi.org	https://doi.org/10.1080/14735784.2020.1857810
catalyst-41952	doi.org	https://doi.org/10.1007/s10886-010-9864-5
catalyst-41952	doi.org	https://doi.org/10.1177/0263276417695866
catalyst-41952	doi.org	https://doi.org/10.1111/maq.12466
catalyst-41952	doi.org	https://doi.org/10.1080/15265161.2017.1299240
catalyst-41952	doi.org	https://doi.org/10.1080/15265161.2017.1299246
catalyst-41952	doi.org	https://doi.org/10.1136/medhum-2021-012348
catalyst-41952	doi.org	https://doi.org/10.1080/15265161.2017.1299245
catalyst-41952	doi.org	https://doi.org/10.1007/s00040-015-0448-9
catalyst-41952	doi.org	https://doi.org/10.1016/j.jaut.2023.103034
catalyst-41952	doi.org	https://doi.org/10.2105%2fajph.2015.302989
catalyst-41952	doi.org	https://doi.org/10.1016/bs.aiip.2020.03.002
catalyst-41952	doi.org	https://doi.org/10.1086/728886
catalyst-41952	doi.org	https://doi.org/10.1016/j.cois.2018.05.002
catalyst-41952	doi.org	https://doi.org/10.1177/1073110519897727
catalyst-41952	doi.org	https://doi.org/10.1111/j.1548-1360.2008.00002.x
catalyst-41952	doi.org	https://doi.org/10.1080/15265161.2017.1299240
catalyst-41952	doi.org	https://doi.org/10.1080/15265161.2017.1299246
catalyst-41952	doi.org	https://doi.org/10.1136/medhum-2021-012348
catalyst-41952	doi.org	https://doi.org/10.1080/15265161.2017.1299245
catalyst-41952	doi.org	https://doi.org/10.1007/s00040-015-0448-9
catalyst-41952	doi.org	https://doi.org/10.1016/j.jaut.2023.103034
catalyst-41952	doi.org	https://doi.org/10.2105%2fajph.2015.302989
catalyst-41952	doi.org	https://doi.org/10.1016/bs.aiip.2020.03.002
catalyst-41952	doi.org	https://doi.org/10.1086/728886
catalyst-41952	doi.org	https://doi.org/10.1016/j.cois.2018.05.002
catalyst-41952	doi.org	https://doi.org/10.1177/1073110519897727
catalyst-41952	doi.org	https://doi.org/10.1111/j.1548-1360.2008.00002.x
catalyst-41952	doi.org	https://doi.org/10.1177/0306312713505003
catalyst-41952	doi.org	https://doi.org/10.1016/j.chom.2023.03.020
catalyst-41952	doi.org	https://doi.org/10.1016/j.humic.2017.05.004
catalyst-41952	www.rebyota.com	https://www.rebyota.com/what-is-rebyota/
catalyst-41952	doi.org	https://doi.org/10.1093/jlb/lsv046
catalyst-41952	doi.org	https://doi.org/10.1146/annurev-ento-022420-074746
catalyst-41952	doi.org	https://doi.org/10.1177/1073110519897729
catalyst-41952	www.statnews.com	https://www.statnews.com/2021/02/23/openbiome-to-winddown-stool-bank-operations/
catalyst-41952	doi.org	https://doi.org/10.1002/ece3.9757
catalyst-41952	www.justice.gov	https://www.justice.gov/usao-ndca/pr/ubiome-co-founders-charged-federalsecurities-health-care-fraud-conspiracies
catalyst-41952	www.fda.gov	https://www.fda.gov/files/drugs/published/exclusivity-and-generic-drugs--whatdoes-it-mean-.pdf
catalyst-41952	doi.org	https://doi.org/10.1177/0306312713505003
catalyst-41952	doi.org	https://doi.org/10.1016/j.chom.2023.03.020
catalyst-41952	doi.org	https://doi.org/10.1016/j.humic.2017.05.004
catalyst-41952	www.rebyota.com	https://www.rebyota.com/what-is-rebyota
catalyst-41952	doi.org	https://doi.org/10.1093/jlb/lsv046
catalyst-41952	doi.org	https://doi.org/10.1146/annurev-ento-022420-074746
catalyst-41952	doi.org	https://doi.org/10.1177/1073110519897729
catalyst-41952	www.statnews.com	https://www.statnews.com/2021/02/23/openbiome-to-wind-down-stool-bank-operations
catalyst-41952	www.statnews.com	https://www.statnews.com/2021/02/23/openbiome-to-wind-down-stool-bank-operations
catalyst-41952	doi.org	https://doi.org/10.1002/ece3.9757
catalyst-41952	www.justice.gov	https://www.justice.gov/usao-ndca/pr/ubiome-co-founders-charged-federal-securities-health-care-fraud-conspiracies
catalyst-41952	www.justice.gov	https://www.justice.gov/usao-ndca/pr/ubiome-co-founders-charged-federal-securities-health-care-fraud-conspiracies
catalyst-41952	www.fda.gov	https://www.fda.gov/files/drugs/published/exclusivity-and-generic-drugs--what-does-it-mean-.pdf
catalyst-41952	www.fda.gov	https://www.fda.gov/files/drugs/published/exclusivity-and-generic-drugs--what-does-it-mean-.pdf
catalyst-41952	www.fda.gov	https://www.fda.gov/industry/medical-products-rare-diseases-andconditions/designating-orphan-product-drugs-and-biological-products
catalyst-41952	www.fda.gov	https://www.fda.gov/newsevents/press-announcements/fda-approves-first-fecal-microbiota-product
catalyst-41952	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidancedocuments/enforcement-policy-regarding-investigational-new-drug-requirementsuse-fecal-microbiota
catalyst-41952	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-approves-first-orallyadministered-fecal-microbiota-product-prevention-recurrence-clostridioides
catalyst-41952	www.fda.gov	https://www.fda.gov/vaccines-blood-biologics/fecalmicrobiota-products
catalyst-41952	doi.org	https://doi.org/10.1007/s00281-018-0716-7
catalyst-41952	www.viome.com	https://www.viome.com/products/gut-health-solutions
catalyst-41952	www.vowst.com	https://www.vowst.com/
catalyst-41952	www.jstor.org	http://www.jstor.org/stable/26646255
catalyst-41952	doi.org	https://doi.org/10.1177/136345930200600304
catalyst-41952	doi.org	https://doi.org/10.2307/j.ctt1p6jht5.26
catalyst-41952	www.fda.gov	https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products
catalyst-41952	www.fda.gov	https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products
catalyst-41952	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-approves-first-fecal-microbiota-product
catalyst-41952	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-approves-first-fecal-microbiota-product
catalyst-41952	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-regarding-investigational-new-drug-requirements-use-fecal-microbiota
catalyst-41952	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-regarding-investigational-new-drug-requirements-use-fecal-microbiota
catalyst-41952	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-regarding-investigational-new-drug-requirements-use-fecal-microbiota
catalyst-41952	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-approves-first-orally-administered-fecal-microbiota-product-prevention-recurrence-clostridioides
catalyst-41952	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-approves-first-orally-administered-fecal-microbiota-product-prevention-recurrence-clostridioides
catalyst-41952	www.fda.gov	https://www.fda.gov/vaccines-blood-biologics/fecal-microbiota-products
catalyst-41952	www.fda.gov	https://www.fda.gov/vaccines-blood-biologics/fecal-microbiota-products
catalyst-41952	doi.org	https://doi.org/10.1007/s00281-018-0716-7
catalyst-41952	www.viome.com	https://www.viome.com/products/gut-health-solutions
catalyst-41952	www.vowst.com	https://www.vowst.com
catalyst-41952	www.jstor.org	http://www.jstor.org/stable/26646255
catalyst-41952	doi.org	https://doi.org/10.1177/136345930200600304
catalyst-41952	doi.org	https://doi.org/10.2307/j.ctt1p6jht5.26
catalyst-41952	doi.org	https://doi.org/10.1111/maq.12328
catalyst-41952	doi.org	https://doi.org/10.1002/fea2.12018
catalyst-41952	www.jstor.org	https://www.jstor.org/stable/26661035
catalyst-41952	doi.org	https://doi.org/10.1073/pnas.1000083107
catalyst-41952	doi.org	https://doi.org/10.1111/maq.12328
catalyst-41952	doi.org	https://doi.org/10.1002/fea2.12018
catalyst-41952	www.jstor.org	https://www.jstor.org/stable/26661035
catalyst-41952	doi.org	https://doi.org/10.1073/pnas.1000083107